ACTAVIS INC

1300 Sawgrass Corporate Pkwy Ste 130, Sunrise, Florida, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

68.0%

Phase 3

27.8%

Not Applicable

2.1%

Phase 4

1.0%

Trial Status Distribution

Completed

95.9%

Recruiting

2.1%

Withdrawn

2.1%

Clinical Trials

Trials sponsored by this organization (97)

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Phase 3

Completed

interventional

Apr 20191,105 participants

Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg

Phase 3

Completed

interventional

Mar 20191,902 participants

Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma

Phase 3

Completed

interventional

Dec 2018999 participants

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

Phase 3

Completed

interventional

Mar 2018448 participants

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Phase 3

Completed

interventional

Oct 2017905 participants

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Phase 3

Completed

interventional

Jan 20171,714 participants

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

Phase 3

Completed

interventional

Aug 2016507 participants

A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea

Phase 3

Completed

interventional

Jul 2016924 participants

Page 1 of 13

Approvals

No approval data available

News

No news articles found

Back to Organizations